Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Bill Ericson
AddedMar 31, 2024
UpdatedMay 31, 2026
Bill Ericson

Bill Ericson

Co-Founder, Venture Law Group

CrunchbaseLinkedIn

Bill Ericson's Career

Venture Law Group
Venture Law Group

Menlo Park, CA, US

Co-Founder
Wildcat Venture Partners
Wildcat Venture Partners

San Mateo, CA, US

Co-Founder
Nlight
Nlight

Vancouver, WA, US

Board Member· Board
Tethys Bioscience
Tethys Bioscience

Emeryville, CA, US

Board Member· Board
Splice Machine
Splice Machine

San Francisco, CA, US

Board Member· Board
AudienceScience
AudienceScience

Bellevue, WA, US

Board Member· Board
HealthTap
HealthTap

Palo Alto, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Bill Ericson's Career

Venture Law Group
Venture Law Group

Menlo Park, CA, US

Co-Founder
Wildcat Venture Partners
Wildcat Venture Partners
Investment FirmInvestment Firm152015San Mateo, CA, US
Co-Founder

Leadership at Wildcat Venture Partners

Bryan StolleBryan StolleCo-Founder
Katherine BarrKatherine BarrCo-Founder
Nlight
Nlight

Vancouver, WA, US

Board Member· Board
Tethys Bioscience
Tethys Bioscience
Public$75.4M752002Emeryville, CA, US
Board Member· Board

Leadership at Tethys Bioscience

Brook ByersBrook ByersBoard Member
George RehmGeorge RehmBoard Member
Randy StrahanRandy StrahanBoard Member
Gregory T WentGregory T WentBoard Member

Similar to Tethys Bioscience

Thetis PharmaceuticalsThetis PharmaceuticalsRidgefield, CT, USDrug Developmentest. 2011Thetis PharmaceuticalsRidgefield, CT, US · est. 2011

Thetis Pharmaceuticals: Specializing in cardio-metabolic, cancer, and autoimmune disease treatments.

Series A · $22.9M30
Gryphon BioGryphon BioSouth San Francisco, CA, USBlood Tests, Diagnosticsest. 2018Gryphon BioSouth San Francisco, CA, US · est. 2018

Gryphon Bio: A preclinical-stage bioconjugate firm innovating in precision medicine and biomarker discovery.

Seed · $10M10
Splice Machine
Splice Machine
Series B$47.5M402012San Francisco, CA, US
Board Member· Board

Leadership at Splice Machine

Bruce ClevelandBruce ClevelandBoard Member
John LeachJohn LeachCo-Founder
Ray LaneRay LaneBoard Member
Monte ZwebenMonte ZwebenBoard Member
Drew HarmanDrew HarmanBoard Member
Jay FulcherJay FulcherBoard Member

Similar to Splice Machine

TectonTectonSan Francisco, CA, USFeature Store, Machine Learningest. 2019TectonSan Francisco, CA, US · est. 2019

Tecton: An enterprise-ready feature store, making world-class machine learning accessible for all.

Series C · $160M157
AudienceScience
AudienceScience

Bellevue, WA, US

Board Member· Board
HealthTap
HealthTap
Late Stage Private$88.3M1002010Palo Alto, CA, US
Board Member· Board

Leadership at HealthTap

Ron GutmanRon GutmanCo-Founder
Sonja PerkinsSonja PerkinsBoard Member
Geoff RutledgeGeoff RutledgeCo-Founder
Bill GossmanBill GossmanBoard Member
Tim ChangTim ChangBoard Member

Bill Ericson's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · Dunamu

People Similar to Bill Ericson

Richard JunRichard JunCo-Founder · BAM VenturesEric SonnierEric SonnierCo-Founder · Local LiftTerence F. KellyTerence F. KellyFounder · Venture ManagementB. H. BoyajianB. H. BoyajianCo-Founder · Private VentureRical HsiehRical HsiehCo-Founder · SentriThomas KnechtThomas KnechtFounder · >>venture>>